Helpline

NAMI Announces the New Class of 2024 NAMI Next Gen Young Adult Advisors

Retrieved on: 
Thursday, January 25, 2024

ARLINGTON, Va., Jan. 25, 2024 /PRNewswire/ -- NAMI is proud to introduce the 2024 NAMI Next Gen class of 10 young adult leaders from diverse backgrounds who will inform and support NAMI efforts by representing the voices of lived experience.

Key Points: 
  • ARLINGTON, Va., Jan. 25, 2024 /PRNewswire/ -- NAMI is proud to introduce the 2024 NAMI Next Gen class of 10 young adult leaders from diverse backgrounds who will inform and support NAMI efforts by representing the voices of lived experience.
  • In 2021, NAMI created and launched the first class of NAMI Next Gen young adult advisors based on one of our guiding principles, "Nothing About Us Without Us."
  • NAMI Next Gen aims to empower young people by providing a platform to share their personal stories to help reduce stigma and support others to realize they are not alone.
  • To achieve this goal, our young adult advisors will share their thoughts, opinions, and feedback to help inform NAMI's youth-focused programs, content, initiatives and new projects.

The Agency Launches Office on Bainbridge Island, Washington

Retrieved on: 
Wednesday, January 17, 2024

LOS ANGELES, Jan. 17, 2024 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new office on Bainbridge Island, Washington. The new locale, which will be known as The Agency Bainbridge Island, is the firm's second office in the state of Washington, joining the brokerage's growing network of offices in the U.S., Canada, Mexico, Central America, the Caribbean, and Europe. The office will be led by accomplished industry veterans and Managing Partners, Mark Middleton and Suzy Legier-Middleton, along with Kevin Pearson who will serve as Managing Broker. The Agency also has an office in Seattle, Washington.

Key Points: 
  • LOS ANGELES, Jan. 17, 2024 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new office on Bainbridge Island, Washington.
  • The new locale, which will be known as The Agency Bainbridge Island, is the firm's second office in the state of Washington, joining the brokerage's growing network of offices in the U.S., Canada, Mexico, Central America, the Caribbean, and Europe.
  • The Agency also has an office in Seattle, Washington.
  • The Agency Bainbridge Island will be located at 168 Winslow Way West, Bainbridge Island, WA, 98110.

National Family Caregivers Month: A Time to Honor Those Caring for a Loved One

Retrieved on: 
Tuesday, October 31, 2023

Washington, DC, Oct. 31, 2023 (GLOBE NEWSWIRE) -- National Family Caregivers Month – celebrated each November – is a time to recognize and honor family caregivers across the country.

Key Points: 
  • Washington, DC, Oct. 31, 2023 (GLOBE NEWSWIRE) -- National Family Caregivers Month – celebrated each November – is a time to recognize and honor family caregivers across the country.
  • Caregiver Action Network (CAN), the nation’s leading family caregiver organization, selects each year’s theme for National Family Caregivers Month and spearheads the celebration of National Family Caregivers Month nationally.
  • This year, Caregiver Action Network is building off the spirit of the 2021 #CaregiverAnd and 2022 #CaregivingHappens campaigns with #CaregiversConnect .
  • The idea behind the campaign is to highlight the many ways that caregivers connect and how important those connections are.

Alzheimer's Association Applauds CMS Decision to Cover PET Imaging for Alzheimer's Disease Diagnosis

Retrieved on: 
Friday, October 13, 2023

CHICAGO, Oct. 13, 2023 /PRNewswire/ -- A valuable Alzheimer's disease diagnostic tool will now be more accessible across the country thanks to a policy change today by the Centers for Medicare & Medicaid Services (CMS). The Alzheimer's Association applauds CMS for taking action to expand coverage of brain amyloid positron emission tomography (PET) imaging for the diagnosis of Alzheimer's disease. In issuing its new policy, CMS said the specific details of the coverage will be made by the Medicare Administrative Contractors (MACs). The Alzheimer's Association urges the MACs to quickly implement broad and equitable coverage for all Medicare beneficiaries.

Key Points: 
  • The Alzheimer's Association applauds CMS for taking action to expand coverage of brain amyloid positron emission tomography (PET) imaging for the diagnosis of Alzheimer's disease.
  • "Amyloid PET scans are a proven tool and can be an important part of Alzheimer's diagnosis and treatment," said Maria C. Carrillo, Ph.D., chief science officer, Alzheimer's Association.
  • "Broader access to amyloid PET scans will enable earlier and more accurate diagnosis, and better care management.
  • The Alzheimer's Association has led the development and implementation of amyloid PET scans in Alzheimer's research, diagnosis and care.

Parents Anonymous® Launches Podcast "Breaking the Stigma" Featuring Unfiltered Conversations Surrounding Today's Mental Health Crisis

Retrieved on: 
Tuesday, July 11, 2023

LOS ANGELES, July 11, 2023 /PRNewswire/ -- Parents Anonymous Inc., a national organization offering free mental health programs and a helpline for both parents and youth, today announces the launch of its podcast "Breaking the Stigma." The podcast highlights candid conversations with individuals who have battled mental health obstacles and their journey to healing.

Key Points: 
  • The podcast highlights candid conversations with individuals who have battled mental health obstacles and their journey to healing.
  • Breaking the Stigma Podcast debuts today, Tuesday, July 11, featuring an interview with R&B singer and songwriter Amina Buddafly, and is co-hosted by DJ Mike Gdnss.
  • Breaking the Stigma will feature powerful interviews and stories from influential and everyday people who share their personal struggles with mental health.
  • Since 1969, Parents Anonymous, Inc. has provided evidence-based emotional support to Parents and Youth nationwide on the National Parent and Youth Helpline®.

Alzheimer's Association Welcomes Announcement of CMS Coverage for FDA-approved Treatments

Retrieved on: 
Friday, July 7, 2023

It is clear that CMS leaders have listened to experts, advocates, people living with Alzheimer's and families.

Key Points: 
  • It is clear that CMS leaders have listened to experts, advocates, people living with Alzheimer's and families.
  • It is reflected in their plan for delivering coverage of traditionally approved treatments proven to deliver meaningful benefit," said Joanne Pike, DrPH, Alzheimer's Association president and CEO.
  • Today's announcement by CMS to open up Medicare coverage comes following extensive efforts by the Alzheimer's Association, bipartisan members of Congress , state attorneys general , clinicians, and, most importantly, advocates from communities all across the country.
  • "We were disappointed, however, that CMS did not take this opportunity to initiate the formal process to reconsider their National Coverage Determination policy .

ALZHEIMER'S ASSOCIATION WELCOMES U.S. FDA TRADITIONAL APPROVAL OF LEQEMBI: FULL DETAILS

Retrieved on: 
Thursday, July 6, 2023

This is the first traditional approval of an Alzheimer's treatment that changes the underlying course of the disease.

Key Points: 
  • This is the first traditional approval of an Alzheimer's treatment that changes the underlying course of the disease.
  • Well-conducted clinical trials clearly demonstrate that removing amyloid from the brain provides measurable, meaningful benefit in people with early Alzheimer's.
  • Leqembi has been on the market since January 2023, when it received accelerated approval from the FDA.
  • "I was in the Leqembi clinical trial, so I am really excited about today's FDA approval.

ALZHEIMER'S ASSOCIATION WELCOMES U.S. FDA TRADITIONAL APPROVAL OF LEQEMBI

Retrieved on: 
Thursday, July 6, 2023

CHICAGO, July 6, 2023 /PRNewswire/ -- The Alzheimer's Association celebrates today's U.S. Food and Drug Administration (FDA) action to grant traditional approval of Leqembi™ (lecanemab, Eisai/Biogen) for the treatment of early Alzheimer's disease.

Key Points: 
  • CHICAGO, July 6, 2023 /PRNewswire/ -- The Alzheimer's Association celebrates today's U.S. Food and Drug Administration (FDA) action to grant traditional approval of Leqembi™ (lecanemab, Eisai/Biogen) for the treatment of early Alzheimer's disease.
  • This is the first Alzheimer's treatment granted traditional approval that changes the underlying course of the disease.
  • With this traditional approval, early detection and diagnosis are even more critical to ensure individuals receive the most benefit at the earliest point possible.
  • For more information or to find a local health care provider, visit the Alzheimer's Association at alz.org , or the Helpline at 800.272.3900.

Pyx Health Launches the Nation's First Loneliness Helpline Available During National Loneliness Awareness Week

Retrieved on: 
Monday, June 12, 2023

TUCSON, Ariz., June 12, 2023 /PRNewswire/ -- America's loneliness epidemic has been in the spotlight recently, with the United States Surgeon General Dr. Vivek Murthy releasing a General Advisory calling attention to the public health crisis. In recognition of this pervasive issue, Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution to manage loneliness and social isolation, has launched the first National Loneliness Helpline, available 24/7 during Loneliness Awareness Week (June 12-18, 2023).

Key Points: 
  • In recognition of this pervasive issue, Pyx Health , a tech-enabled services company that provides health plans and their members an innovative, scalable solution to manage loneliness and social isolation, has launched the first National Loneliness Helpline, available 24/7 during Loneliness Awareness Week (June 12-18, 2023).
  • The Helpline is available to anyone aged 13 and over who is experiencing feelings of loneliness and needs support.
  • The National Loneliness Helpline is available to both English and Spanish callers and will also offer support for youth and LGBTQ+ individuals.
  • "Loneliness can affect individuals of all ages, backgrounds, and demographics," said Terry Randolph, LPC, Chief Program Officer at Pyx Health.

FDA ADVISORY COMMITTEE UNANIMOUSLY CONFIRMS EFFICACY AND CLINICAL BENEFIT OF LEQEMBI FOR EARLY ALZHEIMER'S DISEASE

Retrieved on: 
Friday, June 9, 2023

"The Alzheimer's Association welcomes and celebrates this action by the FDA Advisory Committee to support traditional approval of Leqembi for people with early Alzheimer's," said Joanne Pike, DrPH, Alzheimer's Association president and CEO.

Key Points: 
  • "The Alzheimer's Association welcomes and celebrates this action by the FDA Advisory Committee to support traditional approval of Leqembi for people with early Alzheimer's," said Joanne Pike, DrPH, Alzheimer's Association president and CEO.
  • The Alzheimer's Association and members of the Association's Early Stage Advisory Group each submitted comments urging the Advisory Committee to recommend traditional approval of Leqembi, which was granted accelerated approval in January 2023.
  • "We are in full agreement with the FDA Advisory Committee that Leqembi provides clinical benefit and that this benefit outweighs the risks.
  • Leqembi, an anti-amyloid treatment, changes the course of Alzheimer's and delivers clear clinical benefit for people in the early stages of the disease.